Clinical Laserthermia Systems AB (publ) (STO:CLS.B)

STO:CLS.B Statistics

Total Valuation

STO:CLS.B has a market cap or net worth of SEK 228.76 million. The enterprise value is 213.05 million.

Market Cap	228.76M
Enterprise Value	213.05M

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:CLS.B has 31.17 million shares outstanding. The number of shares has increased by 149.50% in one year.

Current Share Class	31.16M
Shares Outstanding	31.17M
Shares Change (YoY)	+149.50%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	10.68%
Owned by Institutions (%)	11.96%
Float	27.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.76
PB Ratio	4.03
P/TBV Ratio	4.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.55
EV / Sales	10.02
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.38

Financial Position

The company has a current ratio of 3.64, with a Debt / Equity ratio of 0.00.

Current Ratio	3.64
Quick Ratio	2.50
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-1,604.41

Financial Efficiency

Return on equity (ROE) is -66.85% and return on invested capital (ROIC) is -35.64%.

Return on Equity (ROE)	-66.85%
Return on Assets (ROA)	-31.09%
Return on Invested Capital (ROIC)	-35.64%
Return on Capital Employed (ROCE)	-58.05%
Revenue Per Employee	1.64M
Profits Per Employee	-2.95M
Employee Count	13
Asset Turnover	0.32
Inventory Turnover	0.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +112.35% in the last 52 weeks. The beta is -0.15, so STO:CLS.B's price volatility has been lower than the market average.

Beta (5Y)	-0.15
52-Week Price Change	+112.35%
50-Day Moving Average	7.56
200-Day Moving Average	5.87
Relative Strength Index (RSI)	48.83
Average Volume (20 Days)	83,833

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:CLS.B had revenue of SEK 21.27 million and -38.38 million in losses. Loss per share was -1.74.

Revenue	21.27M
Gross Profit	14.28M
Operating Income	-32.99M
Pretax Income	-38.44M
Net Income	-38.38M
EBITDA	-32.68M
EBIT	-32.99M
Loss Per Share	-1.74

Balance Sheet

The company has 13.20 million in cash and 224,000 in debt, with a net cash position of 12.97 million or 0.42 per share.

Cash & Cash Equivalents	13.20M
Total Debt	224,000
Net Cash	12.97M
Net Cash Per Share	0.42
Equity (Book Value)	56.82M
Book Value Per Share	2.32
Working Capital	19.29M

Cash Flow

In the last 12 months, operating cash flow was -33.42 million and capital expenditures -6.19 million, giving a free cash flow of -39.61 million.

Operating Cash Flow	-33.42M
Capital Expenditures	-6.19M
Free Cash Flow	-39.61M
FCF Per Share	-1.27

Margins

Gross margin is 67.13%, with operating and profit margins of -155.10% and -180.45%.

Gross Margin	67.13%
Operating Margin	-155.10%
Pretax Margin	-180.76%
Profit Margin	-180.45%
EBITDA Margin	-153.68%
EBIT Margin	-155.10%
FCF Margin	n/a

Dividends & Yields

STO:CLS.B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-149.50%
Shareholder Yield	-149.50%
Earnings Yield	-16.78%
FCF Yield	-17.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 25, 2024. It was a reverse split with a ratio of 0.005.

Last Split Date	Apr 25, 2024
Split Type	Reverse
Split Ratio	0.005

Scores

STO:CLS.B has an Altman Z-Score of 6.88 and a Piotroski F-Score of 4.

Altman Z-Score	6.88
Piotroski F-Score	4